Today
-1.45%
5 Days
+3.16%
1 Month
+7.89%
6 Months
+26.39%
Year to Date
+95.97%
1 Year
+252.95%
• Teradyne benefits from increased complexity in high-performance computing and artificial intelligence chip testing. • The robotics division shows recovery due to global demand for automation and manufacturing efficiency. • Teradyne reports $3.19 billion in annual revenue and maintains a positive analyst consensus.
• Analysts raised Teradyne price targets citing strong semiconductor and AI infrastructure demand. • Teradyne secured a $140 million defense contract for diagnostic automatic test systems. • Nasdaq-100 inclusion and technical rebalancing caused significant intraday stock price volatility.
• Teradyne shares surged ahead of the company's June 2026 Nasdaq-100 Index inclusion. • Partnerships and new defense contracts support long-term growth in AI and automation sectors. • Stretched valuation multiples and recent insider selling activity have triggered increased intraday volatility.
• Teradyne shares surged following inclusion in the Nasdaq-100 Index. • Semiconductor test equipment demand is rising due to the artificial intelligence boom. • The company secured a multi-year defense contract with the United States Air Force.
• Teradyne shares are rising due to its upcoming inclusion in the Nasdaq-100 Index. • AI hardware and semiconductor testing demand drive Teradyne’s primary long-term revenue growth. • The company secured a $140 million military contract for diagnostic test station kits.
• Teradyne added to Nasdaq-100 Index June 22, 2026. • Secured $139.9 million U.S. DoD contract for test kits. • Reported record Q1 2026 results, revenue up 87% YoY.


| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 7.04% |
| Vanguard Capital Management, LLC | 6.50% |
| Vanguard Portfolio Management, LLC | 5.50% |
| State Street Investment Management (US) | 4.52% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 49.91% |
| Investment Advisor/Hedge Fund | 28.19% |
| Hedge Fund | 7.46% |
| Research Firm | 4.90% |
Related Instruments
Popular Instruments